GRIFOLS | GRF - Cost Of Sales


GRIFOLS reported EUR1.08B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Alcon AG USD 1.18B 26M Mar/2026
Almirall EUR 191.5M 2.29M Dec/2025
Amadeus IT EUR 589.5M 51.6M Mar/2026
Amarin USD 26.05M 1.41M Dec/2025
argenx SE USD 121M 28.69M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Cie Automotive EUR 1.21B 19.7M Dec/2025
Demant DKK 2.89B 188M Dec/2025
Ence Energia y Celulosa EUR 109.33M 21.97M Dec/2025
Essilor EUR 6.06B 741M Dec/2025
Ferrovial EUR 867M 120M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Inditex EUR 4.2B 1.99B Mar/2026
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Smith & Nephew USD 870M 17M Dec/2025
UCB EUR 1.07B 146M Dec/2025
Viscofan EUR 192.48M 10.12M Mar/2026